Literature DB >> 16905153

The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon.

A K Njamnshi1, E N Mbong, A Wonkam, P Ongolo-Zogo, V-de-P Djientcheu, F L Sunjoh, C S Wiysonge, R Sztajzel, D Mbanya, K Ngu Blackett, L Dongmo, W F T Muna.   

Abstract

BACKGROUND AND
PURPOSE: Stroke, a severe and recurrent but preventable complication of sickle cell disease (SCD), has not been well studied in Cameroon. To obtain baseline data towards the development of a national stroke prevention programme in SCD, we studied a sample of sickle cell patients with the aim of determining stroke prevalence, clinical presentation and management practices. PATIENTS AND METHODS: Homozygous sickle cell patients in two centres in Yaounde were screened for stroke, in a cross-sectional study. Stroke was diagnosed clinically and confirmed where possible with brain computerized tomography. The National Institutes of Health Stroke Score (NIHSS) and modified Rankin scale (mRS) were used to assess stroke severity. Management practices were noted from patient charts.
RESULTS: One hundred and twenty patients aged 7 months to 35 years (mean age 13.49+/-8.79 years) were included. Eight cases of stroke (mean age 16.6+/-11.2 years) were identified, giving a stroke prevalence of 6.67%. Cerebral infarction was thrice as common as cerebral hemorrhage and clinical presentation was classical. Cerebral infarction was more frequent in patients aged below 20 years and hemorrhage in those above 20 (p=0.11). The annual recurrence rate was 25%. Missed diagnosis rate by attending physician was 25%. The NIHSS and mRS showed high stroke severity. Stroke management practices were insufficient and no patient received any form of stroke prophylaxis.
CONCLUSION: Stroke prevalence and presentation in sickle cell patients in Yaounde is similar to that observed in developed countries, but the wide management gap calls for rapid action. Our situation is ideal for the study of the natural history of stroke in sickle cell disease.

Entities:  

Mesh:

Year:  2006        PMID: 16905153     DOI: 10.1016/j.jns.2006.07.003

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  24 in total

Review 1.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.

Authors:  Ambroise Wonkam; Khuthala Mnika; Valentina J Ngo Bitoungui; Bernard Chetcha Chemegni; Emile R Chimusa; Collet Dandara; Andre P Kengne
Journal:  Br J Haematol       Date:  2017-12-03       Impact factor: 6.998

4.  Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research.

Authors:  Patrick T McGann; Arielle G Hernandez; Russell E Ware
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

Review 5.  Beta-globin gene haplotypes among cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa?

Authors:  Valentina J Ngo Bitoungui; Gift D Pule; Neil Hanchard; Jeanne Ngogang; Ambroise Wonkam
Journal:  OMICS       Date:  2015-03

6.  Acceptability of prenatal diagnosis by a sample of parents of sickle cell anemia patients in Cameroon (sub-Saharan Africa).

Authors:  Ambroise Wonkam; Alfred K Njamnshi; Dora Mbanya; Jeanne Ngogang; Caryl Zameyo; Fru F Angwafo
Journal:  J Genet Couns       Date:  2011-05-21       Impact factor: 2.537

7.  Relation Between Religious Perspectives and Views on Sickle Cell Disease Research and Associated Public Health Interventions in Ghana.

Authors:  Jemima A Dennis-Antwi; Kwaku Ohene-Frempong; Kofi A Anie; Helen Dzikunu; Veronica A Agyare; Richard Okyere Boadu; Joseph Sarfo Antwi; Mabel K Asafo; Oboshie Anim-Boamah; Augustine K Asubonteng; Solomon Agyei; Ambroise Wonkam; Marsha J Treadwell
Journal:  J Genet Couns       Date:  2018-09-01       Impact factor: 2.537

8.  Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.

Authors:  Amy Geard; Gift D Pule; Bernard Chetcha Chemegni; Valentina J Ngo Bitoungui; Andre P Kengne; Emile R Chimusa; Ambroise Wonkam
Journal:  Br J Haematol       Date:  2017-05-03       Impact factor: 6.998

9.  The excess burden of stroke in hospitalized adults with sickle cell disease.

Authors:  John J Strouse; Lori C Jordan; Sophie Lanzkron; James F Casella
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

10.  Primary stroke prevention for sickle cell disease in north-east Italy: the role of ethnic issues in establishing a Transcranial Doppler screening program.

Authors:  Raffaella Colombatti; Giorgio Meneghetti; Mario Ermani; Marta Pierobon; Laura Sainati
Journal:  Ital J Pediatr       Date:  2009-06-22       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.